PRESS RELEASE – Cognitive Research Corporation Named a Preeminent Contract Research Organization for 2022

Cognitive Research Corporation (CRC) was recently named a top 10 Contract Research Organization by Life Sciences Review. Life Sciences Review is a leading business and technology magazine for the life science industry, offering the latest news from pharma, biotech and medical devices. CRC is proud to be included on its annual list of 10 CROs leading the way in 2022!

Cognitive Research Corporation’s mission is to support innovative companies developing new medicines and therapies to improve mental health and neurological disorders.  As a leading neuroscience clinical research organization (CRO) and cognitive assessment technology company, CRC works with sponsors, specialized clinical trial sites, and CNS experts to bring new drugs through rigorous testing to support FDA submissions and eventual market introduction. For more information, visit www.cogres.com.